Axonics Modulation Technologies

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXNX and other ETFs, options, and stocks.

About AXNX

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women. 

CEO
Raymond Wayne Cohen
CEORaymond Wayne Cohen
Employees
797
Employees797
Headquarters
Irvine, California
HeadquartersIrvine, California
Founded
2012
Founded2012
Employees
797
Employees797

AXNX Key Statistics

Market cap
3.40B
Market cap3.40B
Price-Earnings ratio
-517.68
Price-Earnings ratio-517.68
Dividend yield
—
Dividend yield—
Average volume
812.47K
Average volume812.47K
High today
$66.78
High today$66.78
Low today
$66.50
Low today$66.50
Open price
$66.50
Open price$66.50
Volume
331.82K
Volume331.82K
52 Week high
$69.68
52 Week high$69.68
52 Week low
$47.59
52 Week low$47.59

Analyst ratings

89%

of 9 ratings
Buy
11.1%
Hold
88.9%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.